drugset / Trial / NCT03025087

Hydroxychloroquine and Cognitive Function After Surgery

NCT03025087

Phase 4 Terminated 24 enrolled Duke University
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether hydroxychloroquine decreases the relative leakage of the brain barrier after surgery.

Timeline

Start
2017-06-19
Primary completion
2023-05-22
Completion
2024-04-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydroxychloroquine Small molecule 400 mg
Subject Hydroxychloroquine Small molecule 500 mg
Subject Hydroxychloroquine Small molecule 1000 mg

Indications

No indication recorded.